By Kosaku Narioka
Japan stocks seesaw
Asian stocks were mostly higher Monday, taking their cues from greater stability in crude oil prices and the Russian ruble, along with the Federal Reserve's indication it will take a slow approach to raising interest rates.
By Kosaku Narioka
TOKYO--Most Asian stocks rose Monday, taking their cues from greater stability in crude oil prices and the Russian ruble, along with the U.S. Federal Reserve's indication last week it would take a slow approach to raising interest rates.
By Ross Kelly
SYDNEY--When Australia's Tony Abbott last year promised to become an "infrastructure prime minister"--putting bulldozers on the ground and cranes in the sky--his ambition roused boards in cities from Beijing to New York.
Avnet Electronics Marketing Americas, a business region of Avnet, Inc.
(NYSE: AVT) and global electronics manufacturer and supplier Texas
Instruments Inc. (NASDAQ: TXN) are celebrating their 40-year business
The Babcock & Wilcox Company (B&W) (NYSE:BWC) announced today that a
consortium that includes its Denmark-based subsidiary, Babcock & Wilcox
Vølund A/S (B&W Vølund), has been awarded a $230 million contract to
engineer, procure and construct a waste-to-energy (WTE) power plant near
Israel-based Bank Leumi agreed to pay $400 million to U.S. and New York authorities on Monday and admitted to conspiring to help U.S. taxpayers avoid taxes by stashing assets in offshore accounts with the bank.
By Max Colchester
Barclays PLC has bought out French insurer CNP Assurances' 50% stake in their Spain-based joint-venture, CNP Barclays Vida y Pensiones, for EUR453 million ($554 million), including a special dividend.
Barnes & Noble, Inc. (NYSE: BKS), the nation’s largest retail
bookseller and the leading retailer of content, digital media and
educational products, today announced its January 2015 lineup of free
Storytime events for children and families, all designed to celebrate
the joy of reading.
Baxter International Inc. (NYSE:BAX) today announced that the company
has submitted a biologics license application (BLA) to the United States
(U.S.) Food and Drug Administration (FDA) for the approval of BAX111,
the first highly-purified recombinant von Willebrand Factor (rVWF) in
clinical development as a treatment for patients with von Willebrand
disease, the most common type of inherited bleeding disorder.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.